At NETRI, we believe we can challenge the technologies used in developing new treatments.
NETRI is an industrial start-up developing innovative technologies for the pharmaceutical industry. Its patented microfluidic organs-on-chip technologies allow the creation of standardized and predictive human in vitro models. This allows to anticipate the efficacy of an innovative treatment, to accelerate preclinical research phases, and to reposition compounds on new indications, while limiting animal testing. The use of human neural circuits coupled with multiple cell types opens the way to more personalized medicine as well as faster and more relevant diagnostics. Current application areas include neurological disorders, dermo-cosmetics and neuro-nutrition. Meet us on booth #517.
Brands: We believe we can challenge the technologies used in developing new treatments by building microfluidic neuro-organs-on-chip with a multidisciplinary approach to standardize in-vitro human predictive models.